vimarsana.com

Card image cap

Shares of RxSight, Inc. (NASDAQ:RXST – Get Free Report) have received a consensus recommendation of “Buy” from the six research firms that are presently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in the […]

Related Keywords

United States , Stifel Nicolaus , Ilya Goldshleger , Rxsight Inc , Wells Fargo Company , Vanguard Group Inc , Nasdaq , Riverpark Advisors , Sei Investments Co , Rxsight Company Profile , Manufacturers Life Insurance Company , Needham Company , Morgan Stanley , Get Free Report , Park Advisors , Street Capital , Sei Investments , Get Free , Rxsight Daily , Rxsight , Nasdaq Rxst , Rxst , Medical , Ratings , Consensus ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.